Back
Atara Biotherapeutics Vs. Corvus Pharmaceuticals Industry Stock Comparison
Sell
43
ATRA
Atara Biotherapeutics
Last Price:
10.60
Seasonality Move:
16.06%
Buy
51
CRVS
Corvus Pharmaceuticals
Last Price:
8.94
Seasonality Move:
-3.9%
Sell
43
Atara Biotherapeutics (ATRA)
is a Sell
Is Atara Biotherapeutics a Buy, Sell or Hold?
- The current Atara Biotherapeutics [ATRA] share price is $10.68. The Score for ATRA is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- ATRA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Corvus Pharmaceuticals (CRVS)
is a Buy
Is Corvus Pharmaceuticals a Buy, Sell or Hold?
- The current Corvus Pharmaceuticals [CRVS] share price is $8.24. The Score for CRVS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- CRVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ATRA Stock Price Chart
What is Atara Biotherapeutics's stock price today?
-
The Atara Biotherapeutics share price today is $10.68
The current trend is moderately bearish and ATRA is experiencing slight selling pressure.
CRVS Stock Price Chart
What is Corvus Pharmaceuticals's stock price today?
-
The Corvus Pharmaceuticals share price today is $8.24
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRVS is experiencing slight buying pressure.
ATRA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.77 | Buy |
| Relative Strength Index (14 RSI): | 51.56 | Buy |
| Chaikin Money Flow: | -14360 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.82 - 11.78) | Buy |
| Bollinger Bands (100): | (7.36 - 10.48) | Buy |
CRVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 51.92 | Buy |
| Chaikin Money Flow: | 99400 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.83 - 9.11) | Sell |
| Bollinger Bands (100): | (2.72 - 7.4) | Buy |
ATRA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.95 | Sell |
| 20-day SMA: | 10.59 | Buy |
| 50-day SMA: | 9.14 | Buy |
| 200-day SMA: | 12.56 | Sell |
| 8-day EMA: | 11.39 | Sell |
| 20-day EMA: | 10.77 | Sell |
| 50-day EMA: | 9.79 | Buy |
| 200-day EMA: | 14.79 | Sell |
CRVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.6 | Sell |
| 20-day SMA: | 8.72 | Sell |
| 50-day SMA: | 7.01 | Buy |
| 200-day SMA: | 3.5 | Buy |
| 8-day EMA: | 8.5 | Sell |
| 20-day EMA: | 8.36 | Sell |
| 50-day EMA: | 7.18 | Buy |
| 200-day EMA: | 4.3 | Buy |
Atara Biotherapeutics Earnings Growth & ATRA Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $56.86 per share, and a decrease next year of $2.21 per share.
Corvus Pharmaceuticals Earnings Growth & CRVS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and an increase next year of $0.46 per share.
Atara Biotherapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corvus Pharmaceuticals Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||